药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Butobarbital
GW842166
The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with GW842166.
Butobarbital
Taranabant
The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Taranabant.
Butobarbital
Rimonabant
The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Rimonabant.
Butobarbital
SLV319
The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with SLV319.
Butobarbital
Lumacaftor
The serum concentration of Umeclidinium can be decreased when it is combined with Lumacaftor.
Butobarbital
Epitizide
The serum concentration of Epitizide can be increased when it is combined with Umeclidinium.
Butobarbital
Cyclopenthiazide
The serum concentration of Cyclopenthiazide can be increased when it is combined with Umeclidinium.
Butobarbital
Cimetropium
The risk or severity of adverse effects can be increased when Umeclidinium is combined with Cimetropium.
Butobarbital
Homatropine
The risk or severity of adverse effects can be increased when Umeclidinium is combined with Homatropine.
Butobarbital
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
The risk or severity of adverse effects can be increased when Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione is combined with Umeclidinium.
Butobarbital
Benzhydrocodone
The risk or severity of adverse effects can be increased when Umeclidinium is combined with Benzhydrocodone.
Butobarbital
Tapentadol
The risk or severity of adverse effects can be increased when Tapentadol is combined with Umeclidinium.
Butobarbital
Carfentanil, C-11
The risk or severity of adverse effects can be increased when Carfentanil, C-11 is combined with Umeclidinium.
Butobarbital
Tilidine
The risk or severity of adverse effects can be increased when Tilidine is combined with Umeclidinium.
Butobarbital
Phenazocine
The risk or severity of adverse effects can be increased when Phenazocine is combined with Umeclidinium.
Butobarbital
Phenoperidine
The risk or severity of adverse effects can be increased when Phenoperidine is combined with Umeclidinium.
Butobarbital
Meptazinol
The risk or severity of adverse effects can be increased when Meptazinol is combined with Umeclidinium.
Butobarbital
Nicomorphine
The risk or severity of adverse effects can be increased when Nicomorphine is combined with Umeclidinium.
Butobarbital
Alphaprodine
The risk or severity of adverse effects can be increased when Alphaprodine is combined with Umeclidinium.
Butobarbital
Piritramide
The risk or severity of adverse effects can be increased when Piritramide is combined with Umeclidinium.